Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Committee Composition

Director Name Audit BOD Chair Compensation Lead Independent Director Nom & Corp Gov
Steven Gillis, Ph.D. chairperson of Nom & Corp Gov
Richard Gregory, Ph.D. member of Compensation
Matthew R. Patterson member of Audit
Jeff Poulton member of Audit member of Lead Independent Director
Alise Reicin, M.D. chairperson of Compensation member of Nom & Corp Gov
Mary Thistle Financial Expert chairperson of Audit member of Compensation
Arthur Tzianabos, Ph.D. chairperson of BOD Chair
Legend = Chairperson = Member = Financial Expert